<<

ISSN 1088–9051

May 2007 RESEARCH G ENOME RESEARCHVolume 17 Number 5 17(5):545–666 May 2007 Atp5a1 as a Modifier of Colorectal Cancer ◆ Purifying Selection in Long Non-coding ◆ Darc and Osteoporosis ◆ Genomic Regulatory Blocks and Vertebrate Synteny ◆ PolyScan Indel and SNP Detection

Cold Spring Harbor Press

Edited by Theodore Friedmann, University of California, San Diego, and John Rossi, Beckman Research Institute of the City of Hope, Duarte, California nderstanding gene function and regulation requires rigorous testing in live cells and . Recent advances have provided a variety U of new strategies for delivering DNA and RNA into cells and probing their expression, as well as new clinical applications that rely upon the introduction of genetic material. The vast number of available techniques for clinical and laboratory research often makes selecting the optimal method a difficult process. Gene Transfer: Delivery and Expression of DNA and RNA provides the first comprehensive guide to technical approaches for delivering nucleic acids into cells and organisms and of ensuring (even manipulating) appropriate expression. The detailed, step-by-step protocols cover a variety of methods, both well established and newly evolving. These include viral and nonviral methods of gene delivery, transgenic approaches, strategies for the regulation of transgene expression, and modification of the host response. The introductory matter to each chapter includes concise technical and theoretical discussions with considerations for selection of the appropriate system and strategies for delivery. 2007, 793 pp., illus., appendix, index Hardcover $250 ISBN 0-87969-764-4 Paperback $159 ISBN 0-87969-765-2

1. Introduction, T. Friedmann and J. Rossi 22. γ-2 Herpesvirus Saimiri-based Vectors, 42. Polylysine Copolymers for Gene Delivery, REGULATION OF TRANSGENE VIRAL VECTORS A. Whitehouse S.W. Kim EXPRESSION 2. Retroviral Vectors, K. Cornetta, K.E. Pollok, and 23. Gene Delivery Using HSV/AAV Hybrid 43. PEI Nanoparticles for Targeted Gene Delivery, 60. Conditional of the Genome Using A.D. Miller Amplicon Vectors, O. Saydam, D.L. Glauser, F. Alexis, J. Zeng, and S. Wang Site-specific DNA Recombination, K. Ohtsubo 3. Development of Lentiviral Vectors Expressing and C. Fraefel 44. Cyclodextrin-containing Polycations for Nucleic and J.D. Marth siRNA, G. Tiscornia, O. Singer, and I.M. Verma 24. Polyomaviruses: SV40, D.S. Strayer, C. Mitchell, Acid Delivery, J.D. Heidel 61. Expression and Validation of and 4. HIV-2 Vectors in Human Gene Therapy: Design, D.A. Maier, and C.N. Nichols 45. Bionanocapsules Using the Hepatitis B Short Hairpin RNA in Mammalian Cells, Construction, and Therapeutic Potential, 25. SV40 Packaging: A Pseudovirion Gene Envelope L , T. Yamada, J. Jung, M. Seno, M. Amarzguioui K.V. Morris and F. Wong-Staal Delivery System, C. Kimchi-Sarfaty and A. Kondo, M. Ueda, K. Tanizawa, and S. Kuroda 62. Mifepristone-inducible Gene Regulatory 5. SIV Vectors as Vehicles for DNA Delivery, M.M. Gottesman 46. Formulations of Solid Lipid Nanoparticles for System, K. Schillinger, X. Ye, S. Tsai, and E. Verhoeyen, F.-L. Cosset, and D. Nègre 26. Baculovirus-based Display and Gene Delivery Transfection of Mammalian Cells In Vitro, B.W. O’Malley 6. Production and Use of Feline Immunodeficiency Systems, A.R. Mäkelä, W. Ernst, R. Grabherr, C. Rudolph and J. Rosenecker 63. Dimerizer-mediated Regulation of Gene Virus-based Lentiviral Vectors, D.T. Saenz, and C. Oker-Blom 47. PEGylated Poly-l-lysine DNA Nanoparticles, Expression, V.M. Rivera, L. Berk, and T. Clackson R. Barraza, N. Loewen, W. Teo, and E.M. Poeschla 27. Safe, Simple, and High-capacity Gene Delivery P.B. Davis and T.H. Kowalczyk 64. RheoSwitch System: A Highly Sensitive 7. Transduction of Hematopoietic Cells, into Insect and Vertebrate Cells by Recombinant 48. Water-soluble Lipopolymers and Lipopeptides Ecdysone Receptor-based Gene Regulation M.-J. Li and J.J. Rossi Baculoviruses, K.J. Airenne, O.H. Laitinen, for Delivery, R.I. Mahato, Z. Ye, System Induced by Synthetic Small-molecule 8. Spleen Necrosis Virus-based Vectors, Z. Parveen, A. J. Mähönen, and S. Ylä-Herttuala and S.W. Kim Ligands, P. Kumar and A. Katakam M. Mukhtar, and R.J. Pomerantz 28. Alphaviruses: Semliki Forest Virus and Sindbis 49. Cationic Polysaccharides for DNA Delivery, 65. Site-specific Integration with Phage φC31 9. Foamy Virus Vector Production and Transduction Virus as Gene Delivery Vectors, K. Lundstrom I. Yudovin-Farber, H. Eliyahu, and A.J. Domb Integrase, R.T. Hillman and M.P. Calos of Hematopoietic Cells, N.C. Josephson and 29. Gene Transfer into Mammalian Cells Using 50. Sustained Release of Encoding 66. Creating Zinc Finger Nucleases to Manipulate D.W. Russell Targeted Filamentous Bacteriophage, A. Baird Platelet-derived Growth Factor and Hyaluronan the Genome in a Site-specific Manner Using a 10. Simian Foamy Virus Type-1 Vectors, J. Park and 30. Selection, Isolation, and Identification of Synthase 2 from Cross-linked Hyaluronan Modular-assembly Approach, M. Porteus A. Mergia Targeting Peptides for Ligand-directed Gene Matrices and Films,W. Chen SPECIALIZED TECHNIQUES OF GENE 11. Generation of VSV-G-pseudotyped Retroviral Delivery, M. Trepel, W. Arap, and R. Pasqualini 51. Linear Polyethylenimine: Synthesis and AND VECTOR DELIVERY Vectors, J.-K. Yee 31. Rescue and Propagation of Tropism-modified Transfection Procedures for In Vitro and In 67. Assembly of De Novo Bacterial Artificial 12. Targeted Gene Transfer with Surface-engineered Measles , T. Nakamura and S.J. Russell Vivo, M. Ogris and E. Wagner –based Human Artificial Lentiviral Vectors, E. Verhoeyen and F.-L. Cosset 32. Picornavirus-based Expression Vectors, 52. Protein Nanospheres for Gene Delivery: , J. Basu and H.F. Willard 13. Preparation of Pseudotyped Lentiviral Vectors S. Mueller and E. Wimmer Preparation and In Vitro Transfection Studies 68. Delivery of Naked DNA Using Hydrodynamic Resistant to Inactivation by Serum Complement, 33. Reverse Genetics of Influenza Viruses, with Gelatin Nanoparticles, S. Kommareddy Injection Techniques, D.L. Lewis, M. Noble, G.H. Guibinga and T. Friedmann G.A. Marsh and P. Palese and M.M. Amiji J. Hegge, and J. Wolff 14. Generation of 2A Peptide-linked Multicistronic NONVIRAL TECHNIQUES AND VECTORS 53. Vesicular Stomatitis Virus-G Conjugate, 69. Nonviral Gene Transfer across the Blood-brain Vectors, A.L. Szymczak-Workman, K.M. Vignali, 34. An Overview of Condensing and A. Miyanohara Barrier with Trojan Horse Liposomes, and D.A.A. Vignali Noncondensing Polymeric Systems for Gene 54. High-throughput Methods for Screening W. M. Pardridge 15. Construction of First-generation Adenoviral Delivery, D.B. Shenoy and M.M. Amiji Polymeric Transfection Reagents, G.T. Zugates, 70. Sonoporation: An Efficient Technique for the Vectors, P. J. Ross and R.J. Parks 35. Transfection of Hippocampal Neurons with D.G. Anderson, and R. Langer Introduction of into Chick Embryos, 16. Production and Characterization of Helper- Plasmid DNA Using Calcium Phosphate 55. Poly(Lactic Acid) and Poly(Ethylene Oxide) S. Ohta, O. Yukiko, K. Suzuki, M. Kamimura, dependent Adenoviral Vectors, D.J. Palmer and Coprecipitation, B. Goetze and M. Kiebler Nanoparticles as Carriers for Gene Delivery, K. Tachibana, and G. Yamada P. Ng 36. Gene Delivery to Skin Using Biolistics, N. S. Csaba, A. Sánchez, and M. J. Alonso 71. Genetic Manipulation of Mammalian Cells by 17. and Tissue Targeting, Y. Kawakami and W.C. Heiser 56. Biodegradable Nanoparticles, J.K. Vasir and Microinjection, D.W. Rose D.T. Curiel 37. Optimizing Electrotransfection of Mammalian V. Labhasetwar 72. Magnetofection, C. Plank and J. Rosenecker 18. Stable Producer Cell Lines for AAV Assembly, Cells In Vitro, S. Li 57. Transposon-mediated Delivery of Small 73. Photochemical Internalization for Light-directed G. Chadeuf and A. Salvetti 38. Micro In Utero Electroporation for Efficient Interfering RNA: Sleeping Beauty Transposon, Gene Delivery, A. Bonsted, A. Høgset, E. Wagner, B.S. Fletcher 19. Strategies for the Design of Hybrid Adeno- Gene Targeting in Mouse Embryos, T. Shimogori and K. Berg associated Virus Vectors, A. Asokan and 39. Lipoplex and LPD Nanoparticles for In Vivo 58. Efficient DNA Delivery into Mammalian Cells TRANSGENIC APPROACHES by Displaying the TAT Transduction Domain R.J. Samulski Gene Delivery, S.-D. Li, S. Li, and L. Huang 74. Pronuclear Microinjection in Mice, W. Tsark on Bacteriophage λ, J. Wadia, A. Eguchi, and 20. Recombinant Herpes Simplex Virus Vectors, 40. Bioresponsive Targeted Charge Neutral Lipid 75. Knockdown Transgenic Mice Generated by S.F. Dowdy W.F. Goins, D. M. Krisky, J.B. Wechuck, D. Wolfe, Vesicles for Systemic Gene Delivery, W. Li and Silencing Lentiviral Vectors, O. Singer, 59. Cell-penetrating Peptide-mediated Delivery of S. Huang, and J.C. Glorioso F.C. Szoka, Jr. G. Tiscornia, and I.M. Verma Oligomers, P. Lundberg, 21. Herpes Simplex Virus Type-1-derived Amplicon 41. HVJ Liposomes and HVJ Envelope Vectors, K. Kilk, and Ü. Langel APPENDIX Vectors, W.J. Bowers and H.J. Federoff Y. Kaneda Cautions Subject Index NEW from Lucigen Clone BIG DNA even EASIER! Multiple TIGR had tried several times to make a large insert (AT-rich) Cloning Site library, but the largest size range we could obtain was 4-6 kb. A library in the telN pJAZZ vector had an average insert size of 12 kb and some inserts as large repA cB Cmr as 20 kb. Dr. Robert Coyne, The Institute for Genomic Research (TIGR) Figure 1. Schematic diagram of the pJAZZ-OC linear vector. repA, replica- tion factor and inducible (~2-4 per cell; inducible 5-10 ™ Lucigen’s new BigEasy v2.0 Linear Cloning System makes it a breeze fold); Cmr , chloramphenicol resistance gene; telN, protelomerase gene; cB, EA 7>A@9 5@I /1+ FB EA )& =6% 05BD 5@8 .@>I replication regulator. Approximate positions of terminators (T) are indicated. reduced. You get the sequences of key genes and entire ™ much faster, due to the revolutionary pJAZZ -OC Linear Vector 15-20 kb PCR inserts (Figure 1) in the BigEasy v2.0 kits. 23 kb • Perfect for long PCRs, large cDNAs, and 10-20 kb libraries. Genomes are closed without the need for (Figure 2). 9 kb 10 kb 6 kb 8 kb 6 kb • Highest stability cloning system known. The linear pJAZZ-OC vector avoids insert instability caused by supercoiling in conventional circular vectors. Figure 2. 45C<.75E

50% Discount! for one BigEasy v2.0 Kit (5 reactions) specify discount code GR0507 (valid through July 31, 2007; limited to one per customer) Toll Free: 888 575 9695 www.lucigen.com

Figure 3. Sequence trace of Piromyces DNA successfully cloned in the pJAZZ-OC vector, showing extremely high (96%) AT content.This DNA was unclonable in all other vectors.

Closing centromeric gaps with a Random Shear BAC Library 80 Mb 1 60 0. entional per 40 BACs without Gaps! Centromere 1

conv 20 (~9 Mb) clones Lucigen’s exclusive Random Shear BAC Library Construction Service of

No. BAC 0 14.0 eliminates the problem of under-represented, over-represented, and 13.0 Position on Chromosome 1 (Mb)

Centromeric gaps gaps missing sequences. A Random Shear Library provides complete and T24F19 F13P3 F5E12 F9A12 F25O15 9G9@ :9@A?9 7AG9C5:9" DA .@>I C98F798% Core Lucigen Unlike partial restriction digestion, Random Shear Libraries have equal Random Shear BAC clones representation of all sequences, including those with very few or with 0-T24F19F 0-F13P3R 0-F5E12F 0-F25O15R excessive restriction sites, such as centromeres, telomeres or repeats, 0-F9A12F 0-F9A12R that cause gaps in conventional BAC libraries. These gaps are eliminated Figure 1. An Arabidopsis Random Shear BAC Library (5X coverage) in Random Shear Libraries (Figure 1). A Random Shear BAC Library is 7>AD98 D9G9C5> 9H100 kb (Figure 2). physical and sequencing map (arrows, known sequences; bars, Random Shear clones).

Contact Lucigen for a free quote on a Random Shear BAC Library. MNotlcutRandomShearBACclonesM 888-575-9695 [email protected] kb

150 100 50

Vector Advanced Products for Molecular Figure 2. Potato genomic DNA was randomly sheared, size-selected to >100 kb, and cloned into Lucigen’s NEW pSMART® BAC vector. www.lucigen.com DNA from minipreps was digested with NotI to excise inserts. The vector band is visible at 7 kb. Lanes 1 and 45 (M) contain Lambda size markers. 2005/06

2002/03

2000/01

1998/99

1996/97

1995 2007/08 1993/94 NEB catalog &

1992 technical reference

1990/91 is now available.

1988/89

1986/87

1985/86

1983/84 in a word,essential.

1982/83

1981/82

1980/81

1979 www.neb.com the leader in technology

New England Biolabs Inc. 240 County Road, Ipswich, MA 01938 USA 1-800-NEB-LABS Tel. (978) 927-5054 Fax (978) 921-1350 [email protected] Canada Tel. (800) 387-1095 [email protected] • China Tel. 010-82378266 [email protected] 1978 Germany Tel. 0800/246 5227 [email protected] • Japan Tel. +81 (0)3 5669 6191 [email protected] UK Tel. (0800) 318486 [email protected] For a complete list of international offices, please visit www.neb.com

1975/76 Less iss e. More miRNA amplification, answers, and advancement from the smallest samples.

Powerful and efficient, the NCode™ miRNA Amplification System amplifies mature miRNAs from minute quantities of RNA.

This linear amplification system generates of total RNA, amplification and purification sufficient amounts of material for downstream can be completed within two days, facilitating analysis, from as little as 50 ng of total RNA. studies from the smallest tissue samples. You can count on consistent and accurate The miRNA amplification technology necessary >1,000-fold amplification of mature miRNAs to advance your research is ready. Find it, and Amplification of enriched miRNA from low inputs of total that are ready for immediate labeling and array our complete line of miRNA profiling products, RNA using the NCode™ miRNA Amplification System yields similar data when compared to the direct labeled hybridization. Designed for use with 50–500 ng at www.invitrogen.com/ncode. control, maximizing fidelity and minimizing variability.

© 2007 Invitrogen Corporation. All rights reserved. These products may be covered by one or more Limited Use Label Licenses (see the Invitrogen catalog or our website, www.invitrogen.com). www.roche-applied-science.com

Introducing the NEW Genome Sequencer FLX System More Flexibility, More Applications

Be first to the finish with... Sequencing-by-synthesis: One fragment is bound ■ Increased read lengths averaging 200 to 300 bases per read and amplified on one bead, resulting in one read. ■ Increased number of reads with more than 400,000 reads per run Over 400,000 reads are generated per instrument run. ■ Single-read accuracy greater than 99.5% over 200 bases ■ Consensus-read accuracy greater than 99.99% ...to perform breakthrough science.

Visit www.genome-sequencing.com to learn about the expanding number of peer-reviewed publications appearing weekly.

Roche Diagnostics 454 and GENOME SEQUENCER are trademarks of 454 Sciences Corporation, Branford, CT, USA. Roche Applied Science © 2007 Roche Diagnostics. All rights reserved. Indianapolis, Indiana

Gordon Research Conferences th 75 GRC is holding over 180 meetings in 2007. A few upcoming meetings that may be of particular interest to Genome Research readers are listed below.

GENETIC TOXICOLOGY

July 29 - August 3, 2007 Magdalen College, Oxford, United Kingdom Chair: Antony M. Carr

http://www.grc.org/programs.aspx?year=2007&program=gentox

TOXICOGENOMICS

June 24-29, 2007 Colby-Sawyer College, New London, NH Chairs: Cindy A. Afshari & Christopher A. Bradfield

http://www.grc.org/programs.aspx?year=2007&program=toxico

EVOLUTIONARY & ECOLOGICAL

July 8-13, 2007 Salve Regina University, Newport, RI Chair: Greg Wray

http://www.grc.org/programs.aspx?year=2007&program=evolecol

75 years at the frontiers of science: www.grc.org